as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
5.34%
Downside
1.53%
Upside
52 Week's Low
52 Week's High
81.49%
Downside
53.44%
Upside
Check Ovid Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$94.6M
EPS (TTM)
-0.44
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.86
Industry PE ratio
0PEG Ratio
0EBITDA
-41.2M
Revenue (TTM)
6.7M
Profit Margin
0.00%
Return On Equity TTM
-52.77%
Track how Ovid Therapeutics Inc P/E has moved over time to understand its valuation trends.
Ovid Therapeutics Inc in the last 5 years
Lowest (-6.47x)
June 30, 2024
Industry (0.00x)
November 8, 2025
Today (-2.86x)
November 8, 2025
Highest (2.35x)
June 30, 2021
Today’s Price to Earnings Ratio: -2.86x
Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $94.6M | -73.49% | -2.86 | 0.00% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Ovid Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ovid Therapeutics Inc investment value today
Current value as on today
₹1,05,916
Returns
₹5,916
(+5.92%)
Returns from Ovid Therapeutics Inc Stock
₹769 (+0.77%)
Dollar Returns*
₹5,147 (+5.15%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Ovid Therapeutics Inc. Average target price of $4.01
Get share price movements and forecasts by analysts on Ovid Therapeutics Inc.
What analysts predicted
67.33%UPSIDE
Target Price
$4.01
Current Price
$1.31
Analyzed by
16 Analysts
Target
$4.01
Ovid Therapeutics Inc target price $4.01, a slight upside of 67.33% compared to current price of $1.31. According to 16 analysts rating.
Search interest for Ovid Therapeutics Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -10.23M → -4.68M (in $), with an average increase of 118.5% per quarter
Price Rise
![]()
In the last 3 months, OVID stock has moved up by 158.3%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 76.0K → 6.27M (in $), with an average increase of 69.7% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 907.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 150.2%
| Organisation | Ovid Therapeutics Inc |
| Headquarters | 441 Ninth Avenue, New York, NY, United States, 10001 |
| Industry | Health Technology |
| CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Zhong Zhong Ph.D. | Chief Scientific Officer |
Dr. Amanda Banks M.D. | Chief Development Officer |
Dr. Manal Morsy M.B.A., M.D., PH.D. | Chief Regulatory Officer |
Ms. Victoria Fort | Senior Vice President of Corporate Affairs & Corporate Strategy |
Mr. Charles Ross Carter | Senior VP of Finance & Financial Planning |
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. | CEO & Chairman |
Ms. Margaret Alexander | President & COO |
Mr. Jeffrey A. Rona | Chief Business & Financial Officer and Corporate Secretary |
Dr. Julia Tsai Ph.D. | Senior Vice President of Clinical Development |
Dr. Toshiya Nishi D.V.M. | Head of Epilepsy Research |
Ovid Therapeutics Inc share price today is $1.31 as on at the close of the market. Ovid Therapeutics Inc share today touched a day high of $1.33 and a low of $1.24.
Ovid Therapeutics Inc share touched a 52 week high of $2.01 on and a 52 week low of $0.24 on . Ovid Therapeutics Inc stock price today i.e. is closed at $1.31,which is 34.83% down from its 52 week high and 440.21% up from its 52 week low.
Ovid Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ovid Therapeutics Inc (OVID) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Ovid Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ovid Therapeutics Inc share’s latest price of $1.31 as on November 8, 2025 at 2:29 am IST, you will get 7.6336 shares of Ovid Therapeutics Inc. Learn more about
fractional shares .
Ovid Therapeutics Inc stock has given -73.49% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?